Background/aim-EAT/mcl-1 (EAT), an immediate early gene, functions in a similar way to bcl-2 in neutralising Bax mediated cytotoxicity, suggesting that EAT is a blocker of cell death. The aim of this study was to determine the eVect of overexpression of the human EAT gene on light induced retinal cell apoptosis. The EAT/mcl-1 (EAT) gene was identified by diVerential screening of cDNA libraries derived from a human myeloid leukaemia cell line induced to undergo diVerentiation in culture.
The EAT/mcl-1 (EAT) gene was identified by diVerential screening of cDNA libraries derived from a human myeloid leukaemia cell line induced to undergo diVerentiation in culture. 1 Expression of EAT is transiently induced in these leukaemia cells after stimulation with agents that promote terminal diVerentiation, suggesting that this gene functions as an immediate early gene. The EAT gene is a member of the bcl-2 gene family, because it contains the bcl-2 homology domains 1, 2, 3, and 4.
2-5 bcl-2 related genes have either positive or negative regulatory eVects on apoptosis in vitro and in vivo. [6] [7] [8] Previous studies have established that Bcl-2, Bcl-xL, Bcl-w, Bfl-1, EAT, and A1 are anti-apoptotic molecules while Bax, Bak, Bcl-xS, Bad, Bid, Bik, and Hrk are pro-apoptotic molecules. [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] The rapid increase in expression of EAT produced by differentiating or cytotoxic agents was found to involve an increase in EAT transcription, [20] [21] [22] indicating that the EAT early induction gene is similar to the serum stimulated early response genes. [23] [24] [25] [26] [27] [28] The EAT protein also exhibits rapid turnover (half life of 1-3 hours) 29 because, unlike other bcl-2 family members, the N-terminal region contains two PEST sequences (enriched in proline, glutamic acid, serine, and threonine). The intracellular distribution of EAT appears to be more widespread than Bcl-2. 30 31 The in vivo eVects of bcl-2 related genes have been investigated in transgenic or knockout mice. bcl-2 transgenic mice increased cell survival of B cells, T cells, and thymocytes. [32] [33] [34] [35] Mice deficient for bcl-2 display increased apoptosis in selected tissues. 36 These phenotypes confirm the anti-apoptotic functions established for bcl-2 in vitro. In contrast, bax transgenic mice have increased apoptosis of T cells, whereas mice deficient for bax demonstrate hyperplasia of thymocytes and B cells. [37] [38] [39] Male Bax deficient mice are infertile with atrophic adult testes and an empty epididymis and vas deferens; a complete cessation of mature sperm cell production occurs in these mice. 39 These phenotypes result from the pro-apoptotic functions of Bax.
Apoptosis is the main mechanism of cell loss in induced 40 41 or inherited retinal degeneration 42 43 in animal models, and it may represent the mechanism of cell death in many human retinal diseases. The pathogenesis of retinal degeneration is largely unexplained, and there are no current therapies. Excessive light may enhance the progression and severity of human age related macular degeneration and some forms of retinitis pigmentosa. [44] [45] [46] Animal models of light induced retinal degeneration correlate well with the pathology observed in human donor retinas aVected with retinitis pigmentosa. 47 48 In addition, apoptosis in photoreceptor (PR) cells has been seen in early stages of human retinitis pigmentosa. 49 Likewise, several animal models with inherited retinal degeneration show an increased susceptibility to light damage compared with control animals. 50 Exposure to excessive levels of white light induces PR apoptosis, thus providing an excellent model to analyse degenerative PR loss. 51 PRs overexpressing bcl-2 have been shown to survive light induced insults longer than PRs with normal endogenous levels of bcl-2.
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Expression of bcl-2 protects against PR degeneration in retinal degeneration slow (rds) mice. 53 54 Increased expression of bcl-2 and bcl-xL may be a necessary component in a strategy to inhibit PR cell death. These findings led us to examine the eVect of overexpression of the human EAT gene on light induced retinal cell apoptosis.
Materials and methods

MICE TRANSGENIC FOR HUMAN EAT GENE
To generate transgenic mice that express human EAT, a transgene was constructed with the human EF-1 promoter linked to human EAT (EF1 -EAT) 55 (Fig 1) . A DNA solution (3 µg/ml) was microinjected into the male pronuclei of fertilised mouse eggs taken from superovulated B6C3F1 (C57BL/6 × C3H/He) females. The injected eggs were surgically transferred to the oviducts of B6C3F1 pseudopregnant female mice. Transgene bearing mice were selected by Southern blot analysis of tail DNA (10 µg) hybridised with the EF1 -EAT probe of the 6.7 kb PvuI-PvuI fragment. The founder mice obtained were assigned a number preceded with a letter E-for example, E3 or E12. OVspring were screened by detecting the 1097 bp human EAT fragment in the tail DNA by polymerase chain reaction (PCR) using a set of appropriate primers. The sequences of the primers used were as follows; sense, 5' CTGCATCGAACCATTAGCAG 3', antisense, 5' TACAACCAGTCTGCATACAG 3'.
C3H/He and C57BL/6 mice, which are pigmented, were purchased from Clea Japan (Tokyo, Japan). All mice were maintained in our animal facility under specific pathogen-free conditions. The mice were housed under a controlled photoperiod (12 hours of light, 12 hours of darkness) and temperature (22-25°C) and given water and chow ad labium in cages. The study was approved by the Keio University, School of Medicine, Laboratory Animal Care and Use Committee (No 001106).
SOUTHERN BLOT ANALYSIS
For Southern blot analysis, 5 µg of total genomic DNA was digested to completion with EcoRI, separated by 0.8% agarose gel electrophoresis, and transferred to Hybond N+ filters (Amersham, UK) in 1.5 M NaCl/0.25 N NaOH (Fig 1A) . The membranes were prehybridised at 65°C for 3 hours in 5 × SSPE (1 × SSPE = 0.15 M NaCl, 1 mM EDTA and 0.01 M sodium phosphate buVer), 5 × Denhardt's solution, 1% SDS, and 10 µg of poly A/ml, and then hybridised with the BamHI fragment of human EAT cDNA (2.4 kb) labelled with [ -32 P]-dCTP by the random primer method at 1-3 × 10 9 cpm/µg of specific activity. 56 After overnight hybridisation , blots were washed twice with 1 × SSPE, 1% SDS at room temperature, twice with 1 × SSPE, 1% SDS at 65°C, and twice with 0.1 × SSPE, 0.1% SDS at 65°C, and then exposed to x ray film.
EXPRESSION OF HUMAN EAT IN TRANSGENIC MICE
Expression of human EAT transgene in the mice was examined by reverse transcription and polymerase chain reaction (RT-PCR). Briefly, retina from the mice were snap frozen in liquid nitrogen and homogenised in a microcentrifuge tube. RNA was extracted from these samples by Isogen (Nippon Gene, Japan). To eliminate the possibility of genomic DNA contamination, the RNA samples were further treated with RNase-free DNase and RNase inhibitor at 37°C for 1 hour followed by ethanol precipitation with the use of tRNA as a carrier. Complementary DNA was generated using a first strand cDNA synthesis kit (Pharmacia Biotech, Uppsala, Sweden) and used as a template for PCR. Approximately 1-5 µg of total RNA was transcribed. PCR was carried out in 100 µl reactions containing 1-7 µl cDNA template, 200 mM deoxynucleotide triphosphates, 0.5 mM of each oligonucleotide primer, and 2.5 units of Taq polymerase in 10 mM TRIS HCl buVer, pH 8.8, containing 50 mM KCl, 1.5 mM MgCl 2 . Oligonucleotide primers used for PCR were: 5'-CTGCATCGAACCATTAGCAG (sense) and 5'-TACAACCAGTCTGCATACAG (antisense). They were used to amplify a 1097 bp fragment of human EAT cDNA without detecting the endogenous murine EAT gene. The PCR reaction was performed for 35 cycles with the following parameters: denaturing at 95°C for 1 minute, annealing at 55°C for 1 minute, and elongation at 72°C for 90 seconds. The amplified PCR products were electrophoresed on 0.7% agarose gels and either detected by ultraviolet illumination of ethidium bromide stained gels or transferred to filter and hybridised with 32 P labelled EAT cDNA as a probe.
(B) Schema of the EF1 human EAT (EF1 -EAT) transgene construct. The PvuI fragment was used as the transgene. The same 6.7 kb PvuI fragment was used as a probe for Southern blot hybridisation. This human EAT transgene, driven by the EF-1 promoter, was injected into the fertilised eggs. (C) Expression of the human EAT transgene as assayed in isolated retinas from the transgenic lines. RT-PCR was performed with a primer set which detected only the human EAT gene without detecting the endogenous murine EAT gene (lane 1: non-transgenic mice; lane 2: E12; lane 3: E13; lane 4: no RNA; lane 5: plasmid containing the human EAT gene). Retinas from a non-transgenic mouse and the human EAT DNA served as negative and positive controls, respectively. A 100 bp ladder is shown as a size marker in lane M. actin (729 bp) RT-PCR products are shown to demonstrate the integrity of the isolated RNA (lower section).
Two lines (E13 and E12) of EAT transgenic mice incorporating the EF-1 promoter were utilised. Expression of human EAT was detected by RT-PCR in transgenic mice. Northern blot analysis of various tissues was initially carried out on both lines of transgenic mice to detect human EAT mRNA; however, no signals could be detected. Western blots using an EAT specific monoclonal antibody and a polyclonal antibody were likewise carried out on both lines to detect expression of human EAT protein; however, detectable levels of human EAT could not be observed. In vitro, cells transfected with the same transgene constructs have previously been shown to express the EAT protein by western blot analysis, 57 confirming the integrity of these constructs. Expression of the EAT gene in various organs, as examined by RT-PCR (Fig 1C) revealed ubiquitous expression of EAT in transgenic mice. Strong expression of the transgene was noted in the retina. We concluded that the use of the EF-1 promoter resulted in expression of EAT transgene at levels detectable by RT-PCR.
INDUCTION OF LIGHT DAMAGE
As described by Lavail et al, mice were raised under cyclic room lighting until 5-13 weeks of age and then were placed in a temperature controlled environmental chamber illuminated continuously by 26 white fluorescent bulbs (40 W). Light intensity in the cages ranged from 400 to 500 lux. Groups of animals were examined by electroretinogram (ERG) testing after 3, 5, 7, 9, 10, 13, 14, 16, 18, or 20 weeks in constant lighting, and then killed and tissues were taken for histology. The number of mice examined in each group was as follows: non-transgenic (littermate) at 3 weeks, n = 1; at 5 weeks, n = 1; at 7 weeks, n = 1; at 9 weeks, n = 1; at 10 weeks, n = 1; at 13 weeks, n = 2; at 14 weeks, n = 1; at 16 weeks, n = 1; at 18 weeks, n = 2; at 20 weeks, n = 2; and EAT transgenic at 3 weeks, n = 1; at 5 weeks, n = 1; at 7 weeks, n = 1; at 9 weeks, n = 1; at 10 weeks, n = 1; at 13 weeks, n = 2; at 14 weeks, n = 2; at 16 weeks, n = 1; at 18 weeks, n = 2; at 20 weeks, n = 2.
ELECTROPHYSIOLOGICAL STUDY
Mice were dark adapted for 12 hours before ERG testing as described. Anaesthesia was performed with inhalation of diethyl ether, and the anaesthetised animal was placed on a heating pad (37°C). Pupils were dilated by 0.5% tropicamide. A corneal electrode, which was made from gold, instead of an intravitreous electrode, was used for recording. The ground electrodes were attached subcutaneously in the neck. A 26 gauge needle was placed subcutaneously in the head as a reference electrode. All manipulations were performed under very dim red light. Full field ERGs were elicited with 10 µs flashes of xenon light (20 J) from a Ganzfeld dome on a steady background of 0 cd/m 2 . Responses were diVerentially amplified at a gain of 10 000. Analysis time was 100 ms. Single flash response was recorded. Four or eight flash responses were averaged if it was noisy. Flashes were presented at a rate of about 0.3 Hz manually. The recording band pass was 0.5-100 Hz. The ERG measurements were all made by the investigators blinded to the genotypes of the mice.
The ERG responses were scored by three observers masked with respect to the EAT genotype for the degree of potential rescue. The scores were defined as follows (Fig 2A) : score 0, severe damage with little or no rescue, almost non-recordable; score 1, little damage, a and b-waves observed without oscillatory potentials; score 2, no damage, a, b-wave amplitude and oscillatory potentials well preserved.
Criteria for success were defined as good preservation of the oscillatory potentials-that is, scores of 0 or 1 were considered failure. Data were analysed statistically using KaplanMeier survival analysis with Mantel-Cox log rank test for estimation of success.
HISTOPATHOLOGICAL STUDY
After ERG recordings following a rigid protocol, the anaesthetised animals were killed by cervical dislocation, and the eyes were processed for histology. After fixation for 1-2 days, the posterior segment containing the retina could be sectioned along the vertical meridian. Sections (6 µm thick) were processed and stained with haematoxylin and eosin.
Histological sections cut along the vertical meridian were scored by three observers for the degree of potential rescue. The scores were defined as follows (Fig 3A) : score 0, severe damage with little or no rescue, all photoreceptor inner segment (IS) and outer segment (OS) missing, and the outer nuclear layer (ONL) reduced to less than a single or two rows of photoreceptor nuclei; score 1, moderate damage, the ONL has been reduced to about 3-5 rows of nuclei; disorganised IS and OS are still present; score 2, little damage, photoreceptor IS and some disorganised OS are still present, the ONL still consists of approximately 6-8 rows of nuclei; and score 3, no damage, almost normal structure remained with 9-10 rows of photoreceptor nuclei comprising the ONL. The scores were done with the observers unaware of the EAT genotype and were based on ONL thickness in diVerent regions of the eye as well as PR inner and outer segment length and integrity.
Criteria for success were defined as at least 3-5 rows of nuclei in ONL, where a score of 0 or 1 was considered failure. Data were analysed statistically using Kaplan-Meier survival analysis with Mantel-Cox log rank test for estimation of success. Statistical significance was set at 0.05.
Results
We used ERG to estimate retinal function in mice carrying an EAT transgene under the EF-1 promoter. Light damage was induced in mice by constant illumination. EAT transgenic mice (n = 14) and control littermates (n = 13) were examined by ERG testing at various time points to 20 weeks of constant lighting stimulation. The ERG response score is shown in Table 1A . The mean scores (SD) of ERG dysfunction were significantly lower (p <0.01) in the EAT transgenic mice (0.79 (0.89)) than the littermates (1.69 (0.48)). In addition, Kaplan-Meier curves showed a greater decline in electrophysiological response due to constant light in EAT transgenic mice than in littermates (Fig 2C) . The estimated incidence of electrophysiological retinal damage was 0.0199/mouse/week (95% CI 0.0035-0.0364) in the littermate and 0.0495/mouse/week in the EAT transgenic mice (95% CI 0.0347-0.0500). The ERG responses of the retina deteriorated more markedly in the transgenic mice than in the littermates (p = 0.1156, Kaplan-Meier survival analysis with MantelCox log rank test), suggesting that PR apoptosis under the constant light stimulation is likely to be accelerated by EAT (Fig 2B, C) .
To determine whether this retinal dysfunction is caused by cell death or degeneration, we examined all retinas histopathologically. The results clearly showed that the electrophysiological disturbance was caused by loss of retinal cells. Histopathology scores are shown in Table 1B . There was a trend towards lower mean scores (SD) of histopathological change in the EAT transgenic mice (1.43 (1.22) ) than in littermates (2.31 (0.63)) (p =0.065). The estimated incidence of histopathological retinal damage was 0.0042/mouse/week in littermates (95% CI 0-0.0120) and 0.0419/mouse/week in the EAT transgenic mice (95% CI 0.0286-0.0500). Retinal PR cells were significantly more impaired by constant light in the EAT transgenic mice than the littermate (Fig 3B, p  = 0 .0241, Kaplan-Meier survival analysis with Mantel-Cox log rank test), implying that dysfunction detected by ERG is attributable to retinal cell death.
Discussion
Light induced apoptosis of retinal PRs has been well characterised, but the receptor mediating light damage has not yet been identified. 43 Candidate molecules include prostaglandin synthase, 58 cytochrome oxidase, 59 rhodopsin, 60 and opsins of the cones and the retinal pigment epithelium. 61 c-fos, a transcription factor and a component of AP-1, has been reported to be essential for a specific premitochondrial "private apoptotic pathway" induced by light. 62 In the present study, we have shown that retinal cell death by light was accelerated by EAT, a bcl-2 related gene, using EAT transgenic mice.
The proto-oncogene bcl-2 and its family, which are known to be potent regulators of apoptosis, have attracted great attention in light induced apoptosis (Fig 4) . However, little remains known about their role. Chen et al reported that bcl-2 overexpression reduces PRs apoptosis against sustained illumination.
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However, Joseph and Li reported that the outer layer thickness in bcl-2 or bcl-xL transgenic retinas was not significantly diVerent from non-transgenic ones after exposure to excessive light stimulation. 54 This is explained by the presence of multiple pathways of cell death in PRs that bypass regulation by bcl-2 family proteins.
Similar to bcl-2, EAT has been shown to inhibit apoptosis in vitro and in vivo. 57 63 64 The ratio of anti-apoptotic (death antagonists) to pro-apoptotic bcl-2 related molecules (death agonists) is known to determine whether a cell will undergo apoptosis. This death-life balance is regulated partly by competitive dimerisation between pairs of antagonists and agonists 2 ( Fig  4) . Similar to bcl-2, EAT may heterodimerise with Bax through BH1 and BH2 domains to repress apoptosis. 18 65 66 The interactions of EAT with Bax are more physiologically relevant in cells that fail to express bcl-2, as the bax gene is more widely expressed than bcl-2. 67 The current study is, to our knowledge, the first report to investigate the role of EAT in regulation of retinal PR cell death. The estimated incidence of electrophysiological and morphological retinal damage was increased by EAT.
There were five mice (Tg 41, Tg 472, Lt 34, Lt 18, and Lt 42) defined as "failure" in the electrophysiological study but as "success" in the histopathological findings. There was, however, no mouse defined as "success" in the electrophysiological study and as "failure" in 68 in which although both cell types were protected from cell death on microscopic examination, only the cone cells were functional, and not the rod cells, in signal transduction in ERG analysis.
There are two possible roles of EAT in cells exposed to cytotoxic agents. 20 One possibility is that the rapid increase in EAT might provide an initial viability enhancing or death delaying response. In such cases, EAT might serve an anti-apoptotic function and might allow cells a margin of time to respond to the cytotoxic stimulus (for example, time to decide either to undergo apoptosis or to initiate further measures to prevent cell death). The other possibility is that EAT might have an as yet unproved dual role in the control of cell viability (as is seen with bax and bcl-xL, another member of the bcl-2 family) 69 70 and might in some way contribute to the death that follows increased EAT expression. In the current study, the observation that light induced apoptosis was accelerated in transgenic retina overexpressing EAT supports the latter hypothesis that anti-apoptotic Bcl-2 and Bcl-xL can convert into pro-apoptotic proteins. 71 72 Structural data indicate that the cleavage of Bid, a Bcl-2 related protein, by caspase-8 induces a conformational change that may facilitate exposure of its BH3 domain. 73 74 The BH3 domain may be involved in triggering death, and is conserved in Bax, EAT, Bcl-2, and BclxL. 75 Perhaps like Bcl-2, EAT functions as an anti-apoptotic protein that can be converted into a pro-apoptotic protein by alternative splicing, phosphorylation, proteolytic cleavage, or relocalisation. The potential role of these factors in the chain of events leading to PRs cell death in the retina remains to be investigated. Elucidation of the apoptotic pathway in EAT transgenic mice may lead to identification of other factors that interfere with cell death and of molecular therapeutic strategies that might prevent retinal degeneration. 
